...
首页> 外文期刊>Endoscopy International Open >Results of treatment of esophageal variceal hemorrhage with endoscopic injection of n-butyl-2-cyanoacrylate in patients with Child-Pugh class C cirrhosis
【24h】

Results of treatment of esophageal variceal hemorrhage with endoscopic injection of n-butyl-2-cyanoacrylate in patients with Child-Pugh class C cirrhosis

机译:Child-Pugh C级肝硬化患者内镜下注射2-氰基丙烯酸正丁酯治疗食管静脉曲张破裂出血的结果

获取原文
           

摘要

Background and study aims: The results of endoscopic treatment with elastic band ligation for esophageal variceal bleeding in patients with Child-Pugh class C cirrhosis remain poor. In comparison with treatment with elastic band ligation, we have found lower rates of rebleeding and mortality with n-butyl-2-cyanoacrylate injections. Thus, the aim of the current study was to describe our unit’s 10 years of experience with injection of n-butyl-2-cyanoacrylate to control esophageal variceal ruptures in patients with Child-Pugh class C cirrhosis. Patients and methods: A single-center, retrospective study was conducted. Sixty-three patients with Child-Pugh class C cirrhosis had been admitted to the center with an acute episode of esophageal variceal bleeding. All were treated with injection of n-butyl-2-cyanoacrylate. The patients were assigned to 1 of 2 groups according to their Child-Pugh class C cirrhosis scores: group I (score range, 10 through 13 points) and group II (score, 14 or 15 points). The 3 variables studied were rates of initial failure to control bleeding, failure to prevent rebleeding (secondary prophylaxis), and mortality. Patients in the 2 groups (group I, n?=?50; group II, n?=?13) had similar characteristics. Results: Bleeding was successfully controlled in almost 75?% of the patients during the first 5 days after treatment, with no significant differences observed between groups I and II. There were no significant differences between the 2 groups with respect to mortality rate for the first 5 days after treatment. Thirty-four patients (54?%) were free of bleeding at 6 weeks after treatment, with a significant difference noted between the groups: group I, 64?%, versus group II, 15.4?% (P?
机译:背景与研究目的:Child-Pugh C级肝硬化患者食管静脉曲张破裂出血的内镜下弹性带结扎治疗效果仍然不佳。与弹性带结扎治疗相比,我们发现2-氰基丙烯酸正丁酯注射液的再出血率和死亡率较低。因此,本研究的目的是描述本部门在注射2-氰基丙烯酸正丁酯以控制Child-Pugh C级肝硬化患者食管静脉曲张破裂中的10年经验。患者和方法:进行了单中心回顾性研究。患有Child-Pugh C级肝硬化的63例患者因急性食管静脉曲张破裂出血入院。全部注射2-氰基丙烯酸正丁酯处理。根据Child-Pugh C级肝硬化评分,将患者分为2组中的1组:I组(评分范围为10到13分)和II组(评分为14或15分)。研究的3个变量是控制出血的初始失败率,防止再出血的失败率(二次预防)和死亡率。 2组(I组,n == 50; II组,n == 13)的患者具有相似的特征。结果:在治疗后的前5天中,成功地控制了近75%的患者出血,I组和II组之间没有观察到显着差异。两组之间在治疗后的头5天死亡率方面无显着差异。治疗后6周有34例患者(54%)无出血,两组之间存在显着差异:I组为64%,而II组为15.4%(P <0.001)。总死亡率为44.4%,两组之间存在显着差异:第一组为34%,第二组为84.6%(P <0.001)。结论:内镜下注射2-氰基丙烯酸正丁酯是控制Child-Pugh C级肝硬化评分在10至13分范围内的患者食管静脉曲张破裂出血的有效治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号